Rejected from Nature Microbiology? Where to Submit Next

The useful question is not "which microbiology journal is easier?" It is "what did Nature Microbiology not believe about this manuscript?"

If the editor did not believe the result changed a broad microbiology conversation, the next journal should probably be more specialist. If the editor believed the topic mattered but the evidence did not prove mechanism, functional consequence, ecological relevance, host relevance, public-health significance, or data reliability, the manuscript needs repair before resubmission. If reviewers questioned controls, strain choice, cohort size, sequencing depth, functional validation, isolate relevance, host model, ecological interpretation, data deposition, statistics, or alternative explanations, those problems travel with the paper.

Use the decision letter to classify the failure:

Nature Microbiology is not simply a higher-prestige version of a specialist microbiology journal. It wants microbial discoveries that are visible to a wide microbiology audience. A manuscript can be technically strong and still fail if it reads like a narrow organism, one-host, one-pathogen, one-cohort, one-environment, or one-omics result without a broader microbial principle.

That makes the rejection diagnostically useful. It often means one of three things:

• The system is interesting but the microbial lesson is local. The manuscript reports a strain, pathogen, community, cohort, virus, isolate, enzyme, model, or environmental system, but the broader microbiology consequence is not visible.
• The work is descriptive without functional proof. The paper shows association, abundance, expression, genomic variation, virulence marker, or community shift, but does not prove mechanism or consequence.
• The audience is narrower than the claim. The paper reads as a specialist contribution to PLOS Pathogens, mBio, The ISME Journal, Microbiome, Journal of Virology, Applied and Environmental Microbiology, or a clinical or environmental journal, while the abstract asks for Nature Microbiology-level breadth.

This is why the next submission should be routed by manuscript phenotype, not by prestige adjacency.

This page was researched from current Nature Microbiology aims and scope, content-type guidance, preparing-your-material instructions, editorial-process guidance, the official submit route, and Manusights' existing Nature Microbiology content cluster. The official materials support four practical routing constraints: the paper needs broad microbiology relevance, the evidence and analyses must support the conclusions, the conclusions need wide relevance to the journal's readership, and the manuscript package must make the broad microbial contribution visible to professional editors before peer review.

Most public guidance for rejected Nature Microbiology authors is thin. It tends to point authors back to official instructions or to generic rejection advice. That leaves a useful independent artifact gap: a decision map that turns the rejection reason into the next journal lane and manuscript repair plan.

The specific rejection patterns below are written as a diagnostic, not as a generic journal list. Our analysis of this post-rejection author job is that the useful answer is a routing artifact, because we see authors lose time when they interpret a Nature Microbiology rejection as a prestige problem, but the paper actually has a mechanism, functional evidence, microbiology breadth, system relevance, or audience problem. The best next journal is the one where the manuscript's evidence can support its claim without forcing Nature Microbiology-level breadth that the data cannot carry.

Rebuild for Nature Microbiology only when the manuscript still has a broad microbiology claim and the rejection exposed a repairable weakness. This is most plausible after a desk rejection that points to presentation or journal-family routing, or a reviewer rejection where the missing evidence is achievable.

Good reasons to rebuild:

• The result changes how microbiologists understand a microbial mechanism, host interaction, ecological process, antimicrobial resistance pathway, viral process, microbial community, or public-health problem.
• The rejection questioned framing, abstract logic, first-figure order, mechanism, functional evidence, controls, data deposition, statistics, supplementary evidence, or reviewer routing rather than the underlying result.
• Missing perturbation, rescue, functional validation, isolate comparison, cohort validation, model check, sequencing-quality evidence, or repository detail can be added quickly.
• The strongest microbiology implication was hidden behind organism-specific, cohort-specific, or omics detail.

Bad reasons to rebuild:

• You only want to stay near the Nature Portfolio brand.
• The paper is excellent but clearly specialist.
• The result is a strong descriptive survey, genome report, isolate study, clinical association, environmental dataset, or method validation without a broader microbiology lesson.
• The key limitation requires a new infection model, new functional experiment, new cohort, new field sampling, new isolate panel, new longitudinal design, or different experimental design.

If you rebuild, make the correction visible early. The title, 150-word abstract, first display item, and cover letter should all show the broad microbial principle before specialist detail takes over.

Cell Host & Microbe is often the stronger next route when the manuscript's center of gravity is host-microbe interaction, infection biology, immunity, microbial pathogenesis, or disease mechanism. If the Nature Microbiology rejection says the work is not broad enough, but the host-interface mechanism is strong, CH&M may be a cleaner fit than forcing a general microbiology pitch.

PLOS Pathogens, mBio, and Journal of Virology can be better when the manuscript has strong pathogen or microbial-mechanism value for a focused community. These journals can reward depth in virology, bacteriology, fungal biology, parasitology, microbial genetics, and pathogenesis without requiring the same Nature-branded breadth.

The ISME Journal or Microbiome can be better when the manuscript is fundamentally microbial ecology or microbiome science. If the strongest evidence is community structure, function, ecology, meta-omics, host-associated microbiome dynamics, environmental gradients, or microbial network behavior, those communities may review it more fairly.

Choose these routes when the manuscript can answer:

• What microbial principle, mechanism, or functional consequence does this paper establish?
• Which evidence proves the claim rather than merely showing association?
• Would microbiologists outside the immediate organism, disease, environment, or method niche care before they see the specialist details?
• Does the paper need Nature Microbiology's audience, or a strong specialist audience?

If the answer is mostly "the organism, cohort, genome, or community is interesting," retarget to the venue whose readers work on that system directly.

Many Nature Microbiology rejections are strong papers in the wrong lane.

Move toward PLOS Pathogens, Journal of Virology, Journal of Bacteriology, or mBio when the manuscript is mainly pathogen mechanism, microbial genetics, infection biology, or virology. Move toward The ISME Journal, Microbiome, Environmental Microbiology, or Applied and Environmental Microbiology when the work is microbial ecology, environmental microbiology, microbiome function, biogeochemistry, or applied microbial systems. Move toward Clinical Microbiology and Infection, Journal of Clinical Microbiology, or Emerging Infectious Diseases when the strongest contribution is clinical diagnostics, surveillance, outbreak analysis, antimicrobial resistance, or public-health relevance.

Move toward methods, bioinformatics, food microbiology, industrial microbiology, plant-microbe, soil, oral, animal, or aquatic journals when the contribution is mainly tool development or system-specific. The next editor should not have to guess why a specialist community will care.

The rewrite should reduce Nature Microbiology-specific breadth language. Do not pretend every strong microbiology result needs a flagship broad-microbiology claim. Make the action specific: which reader can use the mechanism, isolate, dataset, model, intervention, assay, community pattern, or public-health finding?

In our pre-submission and post-decision review work with manuscripts aimed at Nature Microbiology, the highest-value repairs are usually not language edits. They are breadth, mechanism, and evidence decisions tied to concrete components: title, 150-word abstract, first display item, functional experiment, model choice, cohort or sample set, repository, Methods, Supplementary Information, cover letter, and limitations.

The editorial triage pattern is predictable enough to test before resubmission: editors decide whether the manuscript advances understanding of the field, whether evidence and analyses support the conclusions, and whether the conclusions have wide relevance to the journal's readership. A specific rejection pattern usually appears when the title promises broad microbial significance but the data prove only a local organism, cohort, pathogen, community, or method case.

Three specific rejection patterns are especially common.

The descriptive-omics trap. The manuscript has impressive sequencing, metagenomics, transcriptomics, proteomics, or comparative genomics, but the central claim remains descriptive. Nature Microbiology is risky when the first figure shows separation, abundance, clustering, or signatures before function. The repair is to add functional evidence, mechanism, perturbation, or a narrower specialist target.

The one-system generality gap. The manuscript studies one pathogen, strain, host model, cohort, community, site, or environmental condition, then claims broad microbiology significance. The repair is to show what generalizes, add independent validation, or write for the community that cares about that system directly.

The consequence-without-causality problem. The paper links a microbe, gene, community, or pathway to disease, ecology, resistance, or public health, but does not prove causal or functional consequence. The repair is to add intervention, rescue, perturbation, longitudinal evidence, mechanistic model, or more honest language.

For Nature Microbiology specifically, we check whether the title, abstract, first display item, cover letter, Methods, data statement, and Supplementary Information all make the same broad-microbiology promise. If one component points to a narrower host-pathogen, virology, microbiome, ecology, clinical, AMR, environmental, or methods journal, the resubmission should follow that signal instead of forcing the manuscript back into a Nature Microbiology story.

The practical lesson is direct: after Nature Microbiology rejection, the manuscript should either become a clearer broad-microbiology paper or a more honest paper for the audience that can use the evidence you actually have. The worst option is a cosmetic resubmission that preserves the same unsupported mechanism, functional, or broad-significance claim.